WallStreetZenWallStreetZen

NYSEMKT: ZOM
Zomedica Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

ZOM past revenue growth

How has ZOM's revenue growth performed historically?
Company
42.44%
Industry
11.19%
Market
13.97%
ZOM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZOM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZOM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZOM earnings and revenue history

Current Revenue
$24.0M
Current Earnings
-$14.5M
Current Profit Margin
-60.4%

ZOM Return on Equity

Current Company
-5.5%
Current Industry
11.5%
Current Market
-9.5%
ZOM's Return on Equity (-5.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZOM announces earnings.

ZOM Return on Assets

Current Company
-5.2%
Current Industry
3.4%
ZOM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZOM Return on Capital Employed

Current Company
-6.4%
Current Industry
6.2%
ZOM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZOM vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZOM$24.01M-$16.47M-$14.50M+2,028.25%N/A
SHOT$4.88M-$16.99M-$17.94M+176.19%N/A
AQST$48.06M-$4.76M-$12.11M-5.21%N/A
OPTN$71.98M-$21.39M-$40.72M+77.89%N/A
ESPR$102.90M-$149.89M-$208.39M-8.59%N/A
View Top Pharmaceutical Stocks

Zomedica Earnings & Revenue FAQ

What were ZOM's earnings last quarter?

On Invalid Date, Zomedica (NYSEMKT: ZOM) reported Q3 2023 earnings per share (EPS) of -$0.00, up 80% year over year. Total Zomedica earnings for the quarter were -$266.00 thousand. In the same quarter last year, Zomedica's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Zomedica stock.

What was ZOM's earnings growth in the past year?

As of Q4 2023, Zomedica's earnings has grown year over year. Zomedica's earnings in the past year totalled -$14.50 million.

What was ZOM's revenue last quarter?

On Invalid Date, Zomedica (NYSEMKT: ZOM) reported Q3 2023 revenue of $6.35 million up 32.89% year over year. In the same quarter last year, Zomedica's revenue was $4.78 million.

What was ZOM's revenue growth in the past year?

As of Q4 2023, Zomedica's revenue has grown 42.44% year over year. This is 31.25 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.19%. Zomedica's revenue in the past year totalled $24.01 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.